These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6102137)

  • 1. Effect of quipazine and fluoxetine on analgesic-induced catalepsy and antinociception in the rat.
    Malec D; Langwinski R
    J Pharm Pharmacol; 1980 Jan; 32(1):71-3. PubMed ID: 6102137
    [No Abstract]   [Full Text] [Related]  

  • 2. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of quipazine and fluoxetine on extinction of a previously-reinforced operant response in rats.
    Beninger RJ
    Pharmacol Biochem Behav; 1984 Oct; 21(4):533-7. PubMed ID: 6334317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic stimulation of prolactin release in the young turkey (Meleagris gallopavo).
    Fehrer SC; Silsby JL; El Halawani ME
    Gen Comp Endocrinol; 1983 Dec; 52(3):400-8. PubMed ID: 6230284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive comparison of quipazine and morphine.
    Minnema DJ; DeWitt L; Rosecrans JA
    Commun Psychopharmacol; 1980; 4(2):115-20. PubMed ID: 7428332
    [No Abstract]   [Full Text] [Related]  

  • 6. Tonic immobility in domestic fowl: anticataleptic effects of quipazine.
    Wallnau LB
    Pharmacol Biochem Behav; 1980 Mar; 12(3):347-52. PubMed ID: 7190287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for serotonergic modulation of progesterone-induced hyperphagia, depression and algesia in female mice.
    Kaur G; Kulkarni SK
    Brain Res; 2002 Jul; 943(2):206-15. PubMed ID: 12101043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on morphine-induced catalepsy in the rat.
    Balsara JJ; Jadhav JH; Muley MP; Chandorkar AG
    J Pharm Pharmacol; 1979 Apr; 31(4):255-7. PubMed ID: 36469
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of imipramine and serotonin-2 agonists and antagonists on serotonin-2 and beta-adrenergic receptors following noradrenergic or serotonergic denervation.
    Eison AS; Eison MS; Yocca FD; Gianutsos G
    Life Sci; 1989; 44(19):1419-27. PubMed ID: 2785627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of blockade of 5-hydroxytryptamine re-uptake on drug-induced antinociception in the rat.
    Sugrue MF; McIndewar I
    J Pharm Pharmacol; 1976 May; 28(5):447-8. PubMed ID: 6756
    [No Abstract]   [Full Text] [Related]  

  • 12. Yohimbine potentiates the anticataleptic action of clonidine against perphenazine-induced catalepsy in rats.
    Shukla VK; Garg SK; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):44-9. PubMed ID: 3767524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
    Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
    Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The actions of neuroleptic drugs and putative serotonin receptor antagonists on LSD and quipazine-induced reductions of brain 5-HIAA concentrations.
    Jacoby JH; Poulakos JJ
    J Pharm Pharmacol; 1977 Dec; 29(12):771-3. PubMed ID: 22629
    [No Abstract]   [Full Text] [Related]  

  • 15. Discriminative stimulus properties of quipazine: direct serotonergic mediation.
    White FJ; Appel JB; Kuhn DM
    Neuropharmacology; 1979 Feb; 18(2):143-51. PubMed ID: 34803
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiserotonergic effect of antidepressives in quipazine-induced headshake behavior in the rat].
    Fischer W; Müller M
    Pharmazie; 1984 Nov; 39(11):776-7. PubMed ID: 6531385
    [No Abstract]   [Full Text] [Related]  

  • 17. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of antihistaminics on cataleptogenic action of analgesics and haloperidol.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(4):293-300. PubMed ID: 6141553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Holland DR; Yen TT; Bemis KG; Stamm NB
    Life Sci; 1979 Oct; 25(14):1237-42. PubMed ID: 316092
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on molindone-induced catalepsy in the rat.
    Balsara JJ; Nandal NV; Gada VP; Chandorkar AG
    J Pharm Pharmacol; 1981 Jun; 33(6):392-4. PubMed ID: 6115017
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.